Uwe Schlokat

642 total citations
27 papers, 527 citations indexed

About

Uwe Schlokat is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Uwe Schlokat has authored 27 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Uwe Schlokat's work include Platelet Disorders and Treatments (13 papers), Complement system in diseases (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Uwe Schlokat is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Complement system in diseases (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Uwe Schlokat collaborates with scholars based in Austria, United States and France. Uwe Schlokat's co-authors include Friedrich Dorner, Bernhard Fischer, Rik Derynck, Arthur D. Levinson, Edward B. Jakobovits, J L Vannice, Artur Mitterer, Michèle Himmelspach, Stephan D. Voss and Wolfgang Mundt and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Uwe Schlokat

25 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Schlokat Austria 16 231 206 134 83 51 27 527
U Jäger Germany 8 163 0.7× 59 0.3× 177 1.3× 87 1.0× 52 1.0× 12 448
Irene Ivhed Sweden 9 287 1.2× 81 0.4× 177 1.3× 58 0.7× 91 1.8× 12 556
Michiyo Hatanaka Japan 16 273 1.2× 117 0.6× 231 1.7× 102 1.2× 39 0.8× 33 670
L. Remels Belgium 11 163 0.7× 86 0.4× 217 1.6× 36 0.4× 138 2.7× 15 541
C F Fox United States 11 135 0.6× 254 1.2× 69 0.5× 43 0.5× 27 0.5× 15 513
Diane Giannola United States 11 345 1.5× 198 1.0× 180 1.3× 121 1.5× 82 1.6× 18 665
Deborah Ferriola United States 13 242 1.0× 108 0.5× 300 2.2× 89 1.1× 57 1.1× 32 707
Marcel Roza Netherlands 8 253 1.1× 142 0.7× 116 0.9× 46 0.6× 156 3.1× 10 541
R G Cook United States 8 153 0.7× 152 0.7× 132 1.0× 47 0.6× 18 0.4× 9 410
M. Fiore United Kingdom 7 136 0.6× 187 0.9× 57 0.4× 33 0.4× 23 0.5× 9 433

Countries citing papers authored by Uwe Schlokat

Since Specialization
Citations

This map shows the geographic impact of Uwe Schlokat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Schlokat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Schlokat more than expected).

Fields of papers citing papers by Uwe Schlokat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Schlokat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Schlokat. The network helps show where Uwe Schlokat may publish in the future.

Co-authorship network of co-authors of Uwe Schlokat

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Schlokat. A scholar is included among the top collaborators of Uwe Schlokat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Schlokat. Uwe Schlokat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwarz, Hans Peter, Uwe Schlokat, Artur Mitterer, et al.. (2002). Recombinant von Willebrand Factor-Insight into Structure and Function through Infusion Studies in Animals with Severe von Willebrand Disease. Seminars in Thrombosis and Hemostasis. 28(2). 215–226. 12 indexed citations
2.
Turecek, Peter L., Katalin Váradi, Uwe Schlokat, et al.. (2002). In vivo and in vitro processing of recombinant pro-von Willebrand factor. Histochemistry and Cell Biology. 117(2). 123–129. 8 indexed citations
3.
Plaimauer, Barbara, Uwe Schlokat, Peter L. Turecek, et al.. (2001). Recombinant von Willebrand Factor: Preclinical Development. Seminars in Thrombosis and Hemostasis. 27(4). 395–404. 16 indexed citations
4.
Plaimauer, Barbara, et al.. (2001). ‘Shed’ furin: mapping of the cleavage determinants and identification of its C-terminus. Biochemical Journal. 354(3). 689–689. 30 indexed citations
5.
Himmelspach, Michèle, Michael Pfleiderer, Bernhard Fischer, et al.. (2000). Recombinant Human Factor X. Thrombosis Research. 97(2). 51–67. 17 indexed citations
6.
Dorner, Friedrich, et al.. (1999). Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.. PubMed. 111(5). 181–91. 3 indexed citations
7.
Fischer, Bernhard, et al.. (1999). Selectivity of von Willebrand factor triplet bands towards heparin binding supports structural model. European Journal Of Haematology. 62(3). 169–173. 2 indexed citations
8.
Schlokat, Uwe, Gabriele Mohr, Michèle Himmelspach, et al.. (1999). Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage. Cytotechnology. 30(1-3). 1–16. 13 indexed citations
9.
Fischer, B., Uwe Schlokat, Michèle Himmelspach, & Friedrich Dorner. (1998). Binding of hirudin to meizothrombin. Protein Engineering Design and Selection. 11(8). 715–721. 13 indexed citations
10.
Roussi, J, P. L. Turecek, M. Bonneau, et al.. (1998). Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease. Blood Coagulation & Fibrinolysis. 9(4). 361–372. 16 indexed citations
11.
Schlokat, Uwe, et al.. (1998). High expression of a B-domain deleted factor VIII gene in a human hepatic cell line. Journal of Biotechnology. 61(3). 165–173. 15 indexed citations
12.
Fischer, B., Uwe Schlokat, Manfred Reiter, Wolfgang Mundt, & Friedrich Dorner. (1997). Biochemical and functional characterization of recombinant von Willebrand factor produced on a large scale. Cellular and Molecular Life Sciences. 53(11-12). 943–950. 17 indexed citations
13.
Turecek, Peter L., Herbert Gritsch, Ludwig Pichler, et al.. (1997). In Vivo Characterization of Recombinant von Willebrand Factor in Dogs With von Willebrand Disease. Blood. 90(9). 3555–3567. 44 indexed citations
14.
Falkner, Falko G., et al.. (1996). Overexpression of Human Prothrombin in Permanent Cell Lines Using a Dominant Selection/Amplification Fusion Marker. Protein Expression and Purification. 8(3). 358–364. 3 indexed citations
15.
16.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1996). Rational Design, Recombinant Preparation, and in Vitro and in Vivo Characterization of Human Prothrombin-derived Hirudin Antagonists. Journal of Biological Chemistry. 271(39). 23737–23742. 2 indexed citations
17.
Fischer, Bernhard, Uwe Schlokat, Artur Mitterer, et al.. (1995). Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co‐expressing recombinant furin. FEBS Letters. 375(3). 259–262. 22 indexed citations
18.
Fischer, Bernhard, et al.. (1994). Structural analysis of recombinant von Willebrand factor: Identification of hetero‐ and homo‐dimers. FEBS Letters. 351(3). 345–348. 18 indexed citations
19.
Jakobovits, Edward B., Uwe Schlokat, J L Vannice, Rik Derynck, & Arthur D. Levinson. (1988). The Human Transforming Growth Factor Alpha Promoter Directs Transcription Initiation from a Single Site in the Absence of a TATA Sequence. Molecular and Cellular Biology. 8(12). 5549–5554. 23 indexed citations
20.
Schlokat, Uwe, et al.. (1986). Nuclear factors binding specific sequences within the immunoglobulin enhancer interact differentially with other enhancer elements.. The EMBO Journal. 5(12). 3251–3258. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U Jäger Breakdown of academic impact, for papers by Irene Ivhed Breakdown of academic impact, for papers by Michiyo Hatanaka Breakdown of academic impact, for papers by L. Remels Breakdown of academic impact, for papers by C F Fox Breakdown of academic impact, for papers by Diane Giannola Breakdown of academic impact, for papers by Deborah Ferriola Breakdown of academic impact, for papers by Marcel Roza Breakdown of academic impact, for papers by R G Cook Breakdown of academic impact, for papers by M. Fiore
Rankless by CCL
2026